Psyence Biomedical (PBM) EBT (2023 - 2025)

Psyence Biomedical has reported EBT for 3 years, with the latest figure at -$1.5 million in Q3 2025.

• On a quarterly basis, EBT fell 230.18% year-over-year to -$1.5 million in Q3 2025; TTM through Sep 2025 was -$3.8 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$6.2 million, down 70.34% from the prior year.
• EBT was -$1.5 million for Q3 2025 at Psyence Biomedical, down from $1.2 million in the prior quarter.
• The five-year high for EBT was $1.2 million in Q3 2024, with the low at -$3.2 million in Q1 2023.
• Average EBT over 3 years is -$939977.2, with a median of -$840571.0 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: EBT jumped 756.26% in 2024, then slumped 230.18% in 2025.
• Over 3 years, EBT stood at -$176165.0 in 2023, then surged by 756.26% to $1.2 million in 2024, then plunged by 230.18% to -$1.5 million in 2025.
• The last three EBT figures came in at -$1.5 million (Q3 2025), $1.2 million (Q3 2024), and -$176165.0 (Q3 2023), per Business Quant data.